SEC Company Response from NORTHWEST BIOTHERAPEUTICS INC (NWBO) (CIK 0001072379) (NWBO) — Dec 21, 2015
NORTHWEST BIOTHERAPEUTICS INC (NWBO) (CIK 0001072379)
Date: Dec. 21, 2015 · CIK: 0001072379 · Accession: 0001144204-15-071983
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-207, 333-207976
Letter
Via Edgar Only United States Securities and Exchange Commission Attention: Suzanne Hayes, Registration Statement on Form S-3 Filed on November 13, 2015 File No. 333-207976
Re: Northwest Biotherapeutics, Inc.
Dear Ms. Hayes:
Please be advised that the undersigned is the duly elected Chief Executive Officer of Northwest Biotherapeutics, Inc. (the "Registrant").
Having been advised that the Commission has no further comments to the Registrant's Form S-3 Registration Statement (File No. 333-207-76), the Registrant hereby requests acceleration of the effective date of the Registration Statement on Tuesday, December 22, 2015 at 4:00 p.m., or as soon thereafter as practicable.
The Registrant hereby acknowledges that:
· should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
· the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
· the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Should you have any questions in regard to this correspondence or any other matter relating to this Registrant’s filing, please do not hesitate to contact me.
Very truly yours,
/s/ Linda F. Powers
Show Raw Text
CORRESP
1
filename1.htm
December 21, 2015
Via Edgar Only
United States Securities and Exchange Commission
Mail Stop 6010
Washington, D.C. 20549
Attention:
Suzanne Hayes,
Assistant Director
Re:
Northwest Biotherapeutics, Inc.
Registration Statement on Form S-3
Filed on November 13, 2015
File No. 333-207976
Dear Ms. Hayes:
Please be advised that
the undersigned is the duly elected Chief Executive Officer of Northwest Biotherapeutics, Inc. (the "Registrant").
Having been advised
that the Commission has no further comments to the Registrant's Form S-3 Registration Statement (File No. 333-207-76), the Registrant
hereby requests acceleration of the effective date of the Registration Statement on Tuesday, December 22, 2015 at 4:00 p.m., or
as soon thereafter as practicable.
The Registrant hereby acknowledges that:
· should
the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission
from taking any action with respect to the filing;
· the
action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve
the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
· the
Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission
or any person under the federal securities laws of the United States.
Should you have any
questions in regard to this correspondence or any other matter relating to this Registrant’s filing, please do not hesitate
to contact me.
Very truly yours,
/s/ Linda F. Powers
Linda F. Powers